<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of vitamin A</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of vitamin A</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of vitamin A</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sassan Pazirandeh, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David L Burns, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 08, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Vitamins are a number of chemically unrelated families of organic substances that cannot be synthesized by humans and must be ingested in the diet in small quantities to facilitate normal metabolism. They are divided into water-soluble and fat-soluble vitamins  (<a class="graphic graphic_table graphicRef63827" href="/z/d/graphic/63827.html" rel="external">table 1</a>).</p><p>Ancient Egyptians recognized that night blindness could be treated by consumption of liver [<a href="#rid1">1</a>]. In the late 1920s, through the efforts of a Swiss scientist named Karrer and his colleagues, the fat-soluble compound in liver was isolated and termed <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> [<a href="#rid2">2</a>].</p><p>This topic review will focus on issues related to <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>. Overviews of the other fat-soluble vitamins, minerals, and water-soluble vitamins are available elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2033.html" rel="external">"Overview of vitamin D"</a> and  <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">"Overview of vitamin E"</a> and  <a class="medical medical_review" href="/z/d/html/2624.html" rel="external">"Overview of vitamin K"</a> and  <a class="medical medical_review" href="/z/d/html/2585.html" rel="external">"Overview of dietary trace elements"</a> and  <a class="medical medical_review" href="/z/d/html/5367.html" rel="external">"Overview of water-soluble vitamins"</a> and  <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">"Vitamin intake and disease prevention"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CHEMISTRY</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> is a subclass of a family of lipid-soluble compounds referred to as retinoic acids. These consist of four isoprenoid units joined in a head-to-tail fashion. There are two main forms of vitamin A: provitamin A carotenoids (<a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a> and others) and preformed vitamin A.</p><p class="bulletIndent1"><span class="glyph">●</span>Provitamin A carotenoids are found in plants. There are many forms of provitamin A, primarily <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>, alpha-carotene, and beta-cryptoxanthin. These are metabolized by mammals into <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>, with varying efficiencies [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preformed <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> (retinol, retinal, retinoic acid, and retinyl esters) is the most active form of vitamin A; it is mostly found in animal sources of food and is also the form supplied by most supplements. Some supplements provide a combination of provitamin A (<a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>) and preformed vitamin A.</p><p></p><p class="headingAnchor" id="H3"><span class="h1">SOURCES</span><span class="headingEndMark"> — </span>The common food sources of preformed <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> (retinols) are liver, kidney, egg yolk, and butter. Provitamin A (<a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>) is mostly found in green leafy vegetables, sweet potatoes, and carrots. Because vitamin A from animal sources or supplements is preformed, it is more likely to cause toxicity than the provitamin A from plant sources. (See <a class="local">'Metabolism'</a> below and <a class="local">'Excess'</a> below.)</p><p class="headingAnchor" id="H4"><span class="h1">METABOLISM</span><span class="headingEndMark"> — </span>The initial steps in metabolism depend on the type of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> ingested. The metabolism of provitamin A (<a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a> and others) into active vitamin A is a highly regulated step, so excessive intake of vitamin A from plant sources is very unlikely to cause toxicity. By contrast, absorption and storage of preformed vitamin A (eg, in animal liver or dietary supplements) is efficient, and toxicity can occur if excessive quantities are ingested. (See <a class="local">'Excess'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>Provitamin A (mostly <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>, from plant sources) must be cleaved to retinal before absorption. This step is subject to feedback regulation, which depends on <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> status.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preformed <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> (retinol, retinal, retinoic acid, and retinyl esters, from supplements or animal sources) is hydrolyzed into retinol in the lumen of the small intestine. A number of retinyl ester hydrolases are involved in this process at the level of the mucosal brush-border [<a href="#rid4">4</a>]. It also appears that pancreatic enzymes have a role in retinoid assimilation [<a href="#rid5">5</a>]. Bile salts form micelles, which allow water solubilization of the products of lipolysis and absorption through the intestinal mucosa. These steps are highly efficient and not subject to feedback regulation.</p><p></p><p>Within the small intestine, retinols are re-esterified into retinyl esters, incorporated into chylomicrons, and excreted into lymphatics and plasma [<a href="#rid3">3</a>]. In the blood, chylomicrons are then broken down into multiple remnants including apolipoproteins B and E, which contain retinyl esters.</p><p>The apolipoproteins are then taken up by the liver via a receptor-mediated endocytosis on the surface of the hepatocytes, and the retinyl esters are released [<a href="#rid3">3</a>]. These are further metabolized to eventually combine with retinol-binding proteins (RBPs) before storage in vitamin A-containing lipid globules within the hepatic stellate cells (formerly known as Ito cells).</p><p>Approximately 50 to 85 percent of the total body retinol is stored in the liver [<a href="#rid6">6</a>]. It is also found in many other tissues in much smaller concentrations. In order for <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> to reach its target organs, it binds to RBP molecules for release into plasma as a retinol-RBP complex.</p><p class="headingAnchor" id="H5"><span class="h1">ACTIONS</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> has a number of biologic actions.</p><p class="headingAnchor" id="H6"><span class="h2">Vision</span><span class="headingEndMark"> — </span>In the eye, <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> has two major roles: prevention of xerophthalmia (abnormalities in corneal and conjunctival development) and phototransduction.</p><p>Two types of retinal photoreceptor cells are involved in the visual process. The cone cells are responsible for the absorption of light and color vision in bright light. The rod cells detect motion and are responsible for night vision. In the rod cells of the retina, all-trans-retinal is converted to 11-cis-retinal, which then combines with a membrane-bound protein called opsin to yield rhodopsin [<a href="#rid7">7,8</a>]. A similar type of reaction occurs in the cone cells of the retina to produce iodopsin. The visual pigments absorb light at different wavelengths depending upon the type of cone cells. As an example, the red-sensitive cone cells absorb any light stimulus in the wavelength of the color red. This leads to the absorption of the three basic colors, red, green, and blue. The light-activated isomerization of these complexes leads to a cascade of hyperpolarization of rod cell membrane, therefore enabling the transmission of light stimuli to the central nervous system [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Cellular differentiation</span><span class="headingEndMark"> — </span>Other than its importance in vision, <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> is crucial to cellular differentiation and integrity in the eye. All the cells in the conjunctiva and the retina have retinol-binding proteins (RBPs), suggesting the dependence of these tissues on retinoic acid. Normal fetal development of the eye also requires adequate vitamin A intake and stores [<a href="#rid9">9</a>]. Studies in vitamin A-depleted animals show abnormal fetal eye tissue development [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H8"><span class="h1">DEFICIENCY</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> deficiency is rarely seen in the United States and other resource-rich countries.</p><p>However, fat-soluble vitamin deficiencies, including <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>, are being increasingly identified in patients that have undergone bariatric surgery. As examples, among patients that have had biliopancreatic diversion or duodenal switch procedures, 69 percent developed vitamin A deficiency [<a href="#rid11">11</a>]. Among gastric bypass patients, vitamin A deficiency was identified in a significant proportion of patients postoperatively; 35 percent at six weeks and 18 percent at one year. Among these patients, vitamin A levels correlated with prealbumin levels. Interestingly, the presence of fat-soluble vitamin deficiency did not correlate to roux limb length [<a href="#rid12">12</a>]. Patients that have had bariatric surgical procedures routinely are supplemented with multivitamins containing vitamin A to prevent deficiency and should be assessed periodically. Management of vitamin A supplementation after bariatric surgery is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Vitamin A'</a>.)</p><p>Nonetheless, the prevalence of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency is approximately 30 percent among children under age 5 worldwide and nearly 50 percent in young children in South Asia and sub-Saharan Africa [<a href="#rid13">13</a>]. These areas have been designated as high priorities for distribution programs, along with a few countries in Central and South America. In many of the countries with high rates of vitamin A deficiency, distribution programs have been disrupted by loss of delivery platforms, leading to a sharp decline in effective supplementation. In many resource-limited countries, night blindness, complete blindness, and advanced stages of xerophthalmia occur in many malnourished children and adults  (<a class="graphic graphic_figure graphicRef101071 graphicRef101072" href="/z/d/graphic/101071.html" rel="external">figure 1A-B</a>) [<a href="#rid14">14,15</a>]. This represents a major public health problem; approximately 500,000 preschool children become blind each year and many die [<a href="#rid16">16</a>]. Routine distribution of vitamin A to children in endemic areas prevents these ophthalmic complications [<a href="#rid17">17,18</a>]. In addition, one study suggests that vitamin A supplementation to children in undernourished populations reduces the long-term risk of hearing loss among those with ear discharge (a marker for otitis) [<a href="#rid19">19</a>].</p><p>Routine distribution of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> to children in endemic areas leads to a modest reduction of childhood mortality of approximately 5 to 15 percent [<a href="#rid13">13</a>]. This was shown in a well-executed cluster-randomized trial (the DEVTA trial) that included more than two million children aged six months to five years in North India, a population with a high frequency of vitamin A deficiency [<a href="#rid20">20</a>]. Supplementation for five years with high-dose vitamin A (200,000 international units every six months, with or without a deworming protocol) reduced the prevalence of severe vitamin A deficiency and ophthalmopathy but did not achieve a significant reduction in mortality (mortality ratio 0.96, 95% CI 0.89-1.03). This finding contrasts with previous smaller studies that suggested that periodic vitamin A supplementation yielded a 12 percent reduction in all-cause mortality and a similar reduction in diarrhea-associated mortality [<a href="#rid21">21</a>]. A meta-analysis that included the DEVTA and eight previous trials yielded a modest weighted average mortality reduction of 11 percent (95% CI 5-16) [<a href="#rid20">20</a>].</p><p><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> deficiency with or without xerophthalmia can also be seen in resource-rich countries in patients with disorders associated with fat malabsorption, such as cystic fibrosis and other causes of pancreatic insufficiency, celiac disease, cholestatic liver disease such as primary biliary cholangitis, small bowel Crohn disease, short bowel syndrome, and in patients who have undergone certain types of bariatric surgery. Xerophthalmia also has been reported in individuals with extremely limited diets due to mental health disorders [<a href="#rid22">22</a>]. Patients with these or other disorders associated with fat malabsorption who experience visual changes, particularly in low light or at night, should be evaluated for vitamin A deficiency. (See  <a class="medical medical_review" href="/z/d/html/5887.html" rel="external">"Vitamin and mineral deficiencies in inflammatory bowel disease", section on 'Vitamin A'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Measurement</span><span class="headingEndMark"> — </span>The diagnosis of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency is usually made by clinical findings but can be supported by measurement of serum retinol levels (levels less than 20 micrograms/dL [0.7 micromol/L] suggest deficiency) [<a href="#rid23">23</a>]. Fasting specimens are preferred [<a href="#rid24">24</a>]. Serum carotene levels are typically low in patients with vitamin A deficiency, and low serum carotene can be used as a surrogate marker of malabsorption and nutritional status.</p><p>Serum <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> concentrations do not reflect total vitamin A stores under certain conditions: Serum retinol levels may be artificially low (ie, underestimate vitamin A stores) in the setting of severe systemic inflammatory disease and severe malnutrition. In setting of inflammation, there is a decrease in many carrier protein levels, including retinol-binding protein (RBP), due to redistribution resulting from capillary leak [<a href="#rid25">25</a>]. In severe malnutrition, serum retinol levels are low because dietary protein, energy, and zinc are required for synthesis of RBP [<a href="#rid3">3</a>]. Conversely, in a patient with vitamin A deficiency, a dose of vitamin A may cause a transient rise in serum retinol concentrations, leading to overestimation of the patient's vitamin A stores.</p><p class="headingAnchor" id="H10"><span class="h2">Clinical manifestations</span></p><p class="bulletIndent1"><span class="glyph">●</span>Xerophthalmia describes a spectrum of eye disease caused by <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency. It is characterized by pathologic dryness of the conjunctiva and cornea, caused by inadequate function of the lacrimal glands, and is manifested by Bitot spots  (<a class="graphic graphic_picture graphicRef72148" href="/z/d/graphic/72148.html" rel="external">picture 1</a>) (areas of abnormal squamous cell proliferation and keratinization of the conjunctiva), progressing to corneal xerosis (dryness) and keratomalacia (softening)  (<a class="graphic graphic_picture graphicRef72297" href="/z/d/graphic/72297.html" rel="external">picture 2</a>) [<a href="#rid3">3,26</a>]. Vitamin A deficiency also causes night blindness (nyctalopia) and retinopathy because vitamin A is a substrate for the photosensitive visual pigments in the retina. The advanced stages of xerophthalmia may be irreversible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poor bone growth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nonspecific dermatologic problems, such as hyperkeratosis, phrynoderma (follicular hyperkeratosis), and the destruction of hair follicles and their replacement with mucus-secreting glands [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Impairment of the humoral and cell mediated immune system via direct and indirect effects on the phagocytes and T cells [<a href="#rid27">27-30</a>]. Supplementation with <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> at the community level in resource-limited countries is recommended by the World Health Organization (WHO) because of its beneficial effects on immunity. (See  <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">"Vitamin intake and disease prevention"</a>.)</p><p></p><p class="headingAnchor" id="H11"><span class="h2">Replacement</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> deficiency is common among populations in resource-limited countries. For populations in which vitamin A deficiency is endemic  (<a class="graphic graphic_figure graphicRef101071 graphicRef101072" href="/z/d/graphic/101071.html" rel="external">figure 1A-B</a>), the WHO recommends the following replacement approaches [<a href="#rid26">26</a>]:</p><p class="headingAnchor" id="H12"><span class="h3">Universal periodic distribution</span><span class="headingEndMark"> — </span>Periodic supplementation is recommended for populations endemic for <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency, at the following doses (where 1 microgram retinol = 3.3 international units) [<a href="#rid26">26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Infants 6 to 12 months of age: 100,000 international units orally (30 mg retinol equivalent) – One dose</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children 12 to 59 months of age: 200,000 international units orally (60 mg retinol equivalent) – Dose repeated every four to six months</p><p></p><p>Pregnant females living in areas where there is a severe public health problem related to <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency should receive vitamin A supplementation to prevent night blindness; supplements should be provided as frequent small doses not exceeding 10,000 international units daily or 25,000 international units, given weekly for a minimum of 12 weeks during pregnancy until delivery [<a href="#rid31">31</a>]. This corresponds approximately to the upper limit (UL) for adults set by the Food and Nutrition Board in the United States  (<a class="graphic graphic_table graphicRef81151" href="/z/d/graphic/81151.html" rel="external">table 2</a>) [<a href="#rid3">3</a>]. High-dose supplements should not be given in pregnancy because of potential teratogenic effects. Replacement should be avoided in the first 60 days of gestation. (See <a class="local">'Teratogenic effects'</a> below.)</p><p>Routine supplementation is no longer recommended for neonates, infants one to five months of age, or to mothers during the postpartum period living in endemic areas [<a href="#rid32">32-34</a>]. In several large studies and systematic reviews, <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> supplementation had no consistent health benefits and may have had side effects in young infants [<a href="#rid35">35</a>]. Supplementation for neonates has been particularly controversial because of mixed results from many large studies [<a href="#rid36">36</a>]. A meta-analysis of 11 randomized trials suggests that neonatal supplementation may reduce infant mortality only in high-risk populations [<a href="#rid37">37</a>]. This analysis found that vitamin A supplementation modestly reduced infant mortality in South Asia (relative risk 0.87, 95% CI 0.77-0.98), a region with high prevalence of vitamin A deficiency and infant mortality, but not in Africa, where these risk factors are lower.</p><p class="headingAnchor" id="H13"><span class="h3">Targeted supplementation for disease</span><span class="headingEndMark"> — </span>For children at high risk of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency, such as those with measles, diarrhea, respiratory disease, or severe malnutrition, who live among populations at risk for vitamin A deficiency, and who have not received supplements within the past one to four months, the WHO recommends an (additional) one-time vitamin A supplementation at the following age-specific doses [<a href="#rid38">38</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Infants &lt; 6 months of age: 50,000 international units orally</p><p class="bulletIndent1"><span class="glyph">●</span>Infants 6 to 12 months of age: 100,000 international units orally</p><p class="bulletIndent1"><span class="glyph">●</span>Children &gt;12 months: 200,000 international units orally</p><p></p><p class="headingAnchor" id="H192219387"><span class="h4">High-risk measles</span><span class="headingEndMark"> — </span>For children with measles who are living in areas where the measles case fatality rate is high, and/or children with severe and complicated measles, the same dose should be given twice, on two successive days [<a href="#rid39">39</a>]. If there are ocular manifestations of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency, a third dose should be given four to six weeks later. (See  <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Vitamin A'</a>.)</p><p class="headingAnchor" id="H192219394"><span class="h4">Xerophthalmia</span><span class="headingEndMark"> — </span>For treatment of xerophthalmia, <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> is given in three doses at the age-specific doses listed above.</p><p>The dose for adolescents and adults is 200,000 international units orally in three doses for a total of 600,000 units [<a href="#rid38">38</a>]. The first dose is given immediately upon diagnosis, the second on the following day, and the third dose at least two weeks later.</p><p>However, females of reproductive age or who are pregnant and have night blindness should be treated with frequent small doses of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>, rather than high doses used for other adults. (See <a class="local">'Universal periodic distribution'</a> above.)</p><p class="headingAnchor" id="H15"><span class="h1">EXCESS</span><span class="headingEndMark"> — </span>The majority of the <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> toxicity cases are due to the chronic ingestion of large amounts of synthetic (or "preformed") vitamin A (approximately 10 times higher than the Recommended Dietary Allowance [RDA], or approximately 50,000 international units) [<a href="#rid40">40</a>]. Water-miscible, emulsified, and solid forms of retinol supplements, which include those in candy-like supplements marketed for children, are more toxic than oil-based preparations [<a href="#rid41">41</a>].</p><p>By contrast, metabolism of provitamin A (<a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>, from plant sources) is highly regulated, so excessive ingestion of this form of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> is very unlikely to cause toxicity. As an example, individuals who ingest large amounts of provitamin A (from plant sources) may develop yellow-tinged skin (carotenemia) without developing vitamin A toxicity. Carotenemia is particularly common among infants and toddlers who are eating large amounts of pureed vegetables (particularly carrots and green leafy vegetables), and may be initially confused with jaundice. The skin discoloration resolves spontaneously if the intake of these foods is reduced. Less commonly, carotenemia may also be caused by some diseases, including nephrosis, diabetes mellitus, anorexia nervosa, liver disease, and hypothyroidism, due to decreased conversion of beta carotene into retinol. (See <a class="local">'Metabolism'</a> above and  <a class="medical medical_review" href="/z/d/html/2868.html" rel="external">"The pediatric physical examination: Back, extremities, nervous system, skin, and lymph nodes", section on 'Yellow discoloration'</a>.)</p><p>Three syndromes of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> toxicity have been recognized: acute, chronic, and teratogenic. Large supplemental doses of retinol are very toxic to the liver, but due to the large storage capacity of the liver for vitamin A, the actual toxic doses are not well established [<a href="#rid42">42</a>].</p><p>Treatment of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> toxicity consists of stopping vitamin A supplements and restricting vitamin A-rich foods (especially sources of pre-formed vitamin A, such as liver, kidney and egg yolk). If the patient has evidence of hepatotoxicity or pseudotumor cerebri, supportive treatment is indicated. Most case reports of chronic toxicity suggest gradual resolution of the symptoms after withdrawal of vitamin A, although hepatic fibrosis may persist [<a href="#rid43">43,44</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Acute toxicity</span><span class="headingEndMark"> — </span>Acute toxicity occurs in adults when a single dose of &gt;660,000 international units (&gt;200,000 micrograms) of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> is ingested. Symptoms include nausea, vomiting, vertigo, and blurry vision [<a href="#rid40">40</a>]. In very high doses, drowsiness, malaise, and recurrent vomiting can follow the initial symptoms listed above. In infants under six months of age, as little as 20,000 international units (6000 micrograms) daily, given briefly (eg, for one month or less), may produce toxic effects [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H17"><span class="h2">Chronic toxicity</span><span class="headingEndMark"> — </span>Chronic toxicity occurs with long-term ingestion of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> doses in amounts higher than 10 times the RDA (ie, toxicity may occur with chronic ingestion of approximately 33,000 international units [10,000 micrograms] of retinol in adults)  (<a class="graphic graphic_table graphicRef81151" href="/z/d/graphic/81151.html" rel="external">table 2</a>) [<a href="#rid46">46</a>]. Some toxic effects of vitamin A also have been observed in infants fed large amounts of chicken liver daily for one month or longer; each serving contained 36,000 international units (11,000 micrograms retinol), which is more than 20 times the RDA for this age group [<a href="#rid47">47</a>]. Signs of chronic toxicity may include ataxia, alopecia, hyperlipidemia, hepatotoxicity, bone and muscle pain, visual impairments, hypercalcemia (rarely), and many other nonspecific signs and symptoms [<a href="#rid48">48</a>].</p><p>Circulating <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> concentrations do not consistently reflect vitamin A stores, because most vitamin A is stored in the liver, so they are not a reliable means of detecting vitamin A toxicity. Patients with hypervitaminosis A may have low, normal, or high serum levels of retinol, depending on the timing, quantity, and form of vitamin A ingested, and the patient's age [<a href="#rid49">49,50</a>].</p><p>Serum retinyl esters in the fasting state are sometimes used as a marker for chronic hypervitaminosis A; retinyl ester concentrations &gt;10 percent of the total <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> pool are considered abnormal (ie, a molar ratio of plasma retinyl esters to the sum of plasma retinol and retinyl esters) [<a href="#rid51">51-53</a>]. However, this ratio may still not reflect hepatic stores long after the toxic ingestion has stopped. Elevated serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and/or calcium, have been reported.</p><p>Symptoms and signs of toxicity include dry skin, nausea, headache, fatigue, irritability, hepatomegaly, alopecia, hyperostosis, and increased cerebrospinal fluid pressure (pseudotumor cerebri). Although children with cystic fibrosis (CF) are at risk for fat-soluble vitamin deficiency due to their pancreatic insufficiency, standard supplementation regimens may lead to excessive levels of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>. In one study of children with CF who were given standard supplements, total vitamin A intake and serum retinol values were elevated, raising concerns about the possibility of chronic toxicity which may contribute to CF-associated liver and bone disease [<a href="#rid54">54</a>]. (See  <a class="medical medical_review" href="/z/d/html/5882.html" rel="external">"Cystic fibrosis: Nutritional issues", section on 'Vitamin A'</a>.)</p><p>Hepatotoxicity can lead to cirrhosis and has been associated with veno-occlusive disease [<a href="#rid42">42,50</a>]. A prominent histologic finding is the proliferation of hepatic stellate cells. Several factors can increase the toxicity of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>, including underlying liver and kidney disease, alcoholism, and the use of some drugs, such as tetracyclines.</p><p class="headingAnchor" id="H18"><span class="h2">Adverse effects on bone</span><span class="headingEndMark"> — </span>There is some evidence that intake levels of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> in the high-normal range may have adverse effects on bone health. In a prospective cohort study of postmenopausal females, long-term intake of a diet high in retinol (vitamin A) was associated with an increased risk of osteoporotic fractures [<a href="#rid55">55</a>]. Similarly, high serum retinol levels were associated with an increased fracture risk in men [<a href="#rid56">56</a>]. Thus high doses of vitamin A may compromise bone health, but the threshold at which clinically relevant effects are seen remains to be determined [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/z/d/html/2036.html" rel="external">"Drugs that affect bone metabolism", section on 'Vitamin A and synthetic retinoids'</a>.)</p><p class="headingAnchor" id="H1486506916"><span class="h2">Cancer</span><span class="headingEndMark"> — </span>Diets rich in beta carotene appear to be associated with lower risks of cancer. However, clinical trials of beta carotene supplementation have not confirmed a beneficial effect, and some suggest that beta carotene supplements may modestly <strong>increase</strong> the risk for lung cancer but not other cancers. (See  <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">"Vitamin intake and disease prevention", section on 'Vitamin A and the carotenoids'</a> and  <a class="medical medical_review" href="/z/d/html/4604.html" rel="external">"Chemoprevention of lung cancer", section on 'Vitamins and minerals'</a>.)</p><p class="headingAnchor" id="H19"><span class="h2">Teratogenic effects</span><span class="headingEndMark"> — </span>Retinoic acid has been known to be very teratogenic in the first trimester of pregnancy, leading to spontaneous abortions and fetal malformations, including microcephaly and cardiac anomalies [<a href="#rid46">46</a>]. Effects may occur at doses only several times the RDA [<a href="#rid58">58</a>]. Many animal models as well as human studies have shown high incidence of birth anomalies in mothers who ingested therapeutic doses of retinoic acid for dermatologic uses [<a href="#rid46">46</a>]. A safe upper limit for <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> intake during pregnancy has been recognized at approximately 10,000 international units daily (approximately 3000 micrograms) [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H20"><span class="h1">THERAPEUTIC USES</span><span class="headingEndMark"> — </span>Retinoic acid and carotenoids have several therapeutic uses.</p><p class="headingAnchor" id="H21"><span class="h2">Measles</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> treatment of children with measles infection in resource-limited countries appears to reduce complications and mortality, although effects on blindness have not been evaluated [<a href="#rid59">59,60</a>]. Thus, vitamin A treatment is recommended for children with measles in resource-limited countries and other areas in which vitamin A deficiency is endemic, and in selected circumstances in developed countries. (See  <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Vitamin A'</a>.)</p><p class="headingAnchor" id="H22"><span class="h2">Dermatology</span><span class="headingEndMark"> — </span>Retinoic acid has been used for many hyperkeratotic and hyperproliferative disorders of skin. Synthetic oxidative metabolites of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> such as <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">isotretinoin</a> can be used topically or systemically for treatment of a variety of skin disorders. Systemic forms have been used in some forms of psoriasis and other disorders of keratinization and even skin cancer. 13-cis-retinoic acid reduces the proliferation of sebaceous glands, and due to such properties it is used for treatment of acne and acne-related disorders. At the lower range of the toxic dose, some of the conjugated forms of retinoic acids (ie, retinol beta-glucuronide) have been used as topical creams or ointments for hyperpigmentation or for reducing wrinkling associated with sun exposure [<a href="#rid61">61</a>].</p><p class="headingAnchor" id="H23"><span class="h2">Atherosclerosis</span><span class="headingEndMark"> — </span>Because carotenoids are antioxidants, they were investigated for possible prevention of cardiovascular disease. However, randomized trials of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> and <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a> have shown no benefit for primary or secondary prevention of coronary heart disease; furthermore, there is some evidence that beta-carotene supplementation may increase mortality from cardiovascular disease and may increase the risk of lung cancer. Therefore, in resource-rich countries where dietary intake of vitamin A is generally adequate, supplementing with vitamin A for disease prevention is not recommended. (See <a class="local">'Cancer'</a> above and  <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">"Vitamin intake and disease prevention"</a>.)</p><p class="headingAnchor" id="H24"><span class="h2">Acute promyelocytic leukemia</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9262" href="/z/d/drug information/9262.html" rel="external">All-trans retinoic acid</a> (ATRA, or tretinoin) is a synthetic oxidative metabolite of retinoic acid and has been used in acute promyelocytic leukemia (a subgroup of acute myelocytic leukemia). (See  <a class="medical medical_review" href="/z/d/html/4527.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults"</a>.)</p><p>Initial studies demonstrated a remarkable response to high-dose daily treatment with all-trans-retinoic acid (approximately 45 mg/m<sup>2</sup>/day) [<a href="#rid62">62</a>]. However, later experience demonstrated that such high doses can lead to a dangerous condition known as the "differentiation syndrome" (previously "retinoic acid syndrome") characterized by respiratory distress, fevers, kidney failure, and hypotension. Because a large number of patients who developed this have died, the drug is administered for short periods of time, in conjunction with other standard chemotherapy [<a href="#rid62">62</a>]. (See  <a class="medical medical_review" href="/z/d/html/4351.html" rel="external">"Differentiation syndrome associated with treatment of acute leukemia"</a>.)</p><p class="headingAnchor" id="H3594713848"><span class="h2">Very low birthweight infants</span><span class="headingEndMark"> — </span>Limited evidence suggests that <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> supplementation may help to prevent bronchopulmonary dysplasia in very low birthweight infants, as discussed in a separate topic review [<a href="#rid63">63,64</a>]. There is no good clinical evidence for a role in preventing retinopathy of prematurity or necrotizing enterocolitis [<a href="#rid65">65</a>]. (See  <a class="medical medical_review" href="/z/d/html/4992.html" rel="external">"Bronchopulmonary dysplasia (BPD): Prevention"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">REQUIREMENTS</span></p><p class="headingAnchor" id="H26"><span class="h2">General population</span><span class="headingEndMark"> — </span>The Recommended Dietary Allowance (RDA) for <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> is given as retinol activity equivalents (RAE), where one RAE = 1 microgram retinol or 3.3 international units [<a href="#rid3">3</a>].</p><p>The RDA for adult males is 3000 international units (900 micrograms retinol) daily, and for females it is 2300 international units (700 micrograms retinol) daily. The RDA for other groups is shown in the table  (<a class="graphic graphic_table graphicRef81151" href="/z/d/graphic/81151.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H27"><span class="h2">Special populations</span><span class="headingEndMark"> — </span>Individuals with clinically significant fat malabsorption due to pancreatic insufficiency or other digestive disorders are at risk for deficiency of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> and other fat-soluble vitamins.</p><p class="bulletIndent1"><span class="glyph">●</span>Pancreatic insufficiency – Patients with cystic fibrosis or Shwachman-Diamond syndrome are routinely treated with supplements of fat-soluble vitamins, which provide doses that are several-fold higher than the RDA. Patients with chronic pancreatitis generally do not develop clinically significant malabsorption and related vitamin deficiencies until almost all pancreatic function is lost.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/5882.html" rel="external">"Cystic fibrosis: Nutritional issues", section on 'Fat-soluble vitamins'</a>.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/5914.html" rel="external">"Shwachman-Diamond syndrome", section on 'GI/nutrition'</a>.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/5649.html" rel="external">"Chronic pancreatitis: Clinical manifestations and diagnosis in adults", section on 'Steatorrhea'</a> and  <a class="medical medical_review" href="/z/d/html/5649.html" rel="external">"Chronic pancreatitis: Clinical manifestations and diagnosis in adults", section on 'Laboratory findings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic liver disease – Individuals with chronic liver disease are typically treated with a standard multivitamin that includes <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>. If vitamin A deficiency is detected in these patients, standard replacement doses should be given. High levels of alcohol consumption appear to potentiate the hepatotoxic effects of vitamin A [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/z/d/html/3598.html" rel="external">"Nutritional issues in adult patients with cirrhosis"</a>.)</p><p></p><p class="bulletIndent1">Individuals with marked cholestasis may require higher doses of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> and other fat-soluble vitamins in order to maintain adequate levels. Children with cholestatic liver disease often require between 5000 and 25,000 international units (1500 to 7500 micrograms retinol) daily of water-miscible vitamin A [<a href="#rid67">67,68</a>]. For patients treated with these high doses of vitamin A, monitoring for clinical or laboratory evidence of vitamin A toxicity (usually assayed as serum retinyl esters in the fasting state) is recommended [<a href="#rid69">69</a>]. (See <a class="local">'Replacement'</a> above and <a class="local">'Chronic toxicity'</a> above and  <a class="medical medical_review" href="/z/d/html/3623.html" rel="external">"Overview of the management of primary biliary cholangitis", section on 'Fat-soluble vitamins'</a> and  <a class="medical medical_review" href="/z/d/html/660.html" rel="external">"Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis", section on 'Steatorrhea and vitamin deficiency'</a> and  <a class="medical medical_review" href="/z/d/html/14369.html" rel="external">"Biliary atresia", section on 'Fat-soluble vitamin supplements'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bariatric surgery – Recommendations for vitamin supplementation after bariatric surgery are discussed in a separate topic review. (See  <a class="medical medical_review" href="/z/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management"</a> and  <a class="medical medical_review" href="/z/d/html/5880.html" rel="external">"Surgical management of severe obesity in adolescents", section on 'Nutritional supplements'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Short bowel syndrome – For individuals with short bowel syndrome, the need for vitamin supplementation depends on the degree of fat malabsorption and whether the patient is receiving parenteral versus enteral nutrition. Vitamin supplements should be guided by regular assessment of nutritional status in the individual patient, particularly during transitions off of <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a>. (See  <a class="medical medical_review" href="/z/d/html/5894.html" rel="external">"Management of short bowel syndrome in children", section on 'Common micronutrient deficiencies'</a> and  <a class="medical medical_review" href="/z/d/html/4773.html" rel="external">"Management of short bowel syndrome in adults", section on 'Weaning parenteral nutrition'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Crohn disease – Patients with Crohn disease and extensive small bowel involvement are at risk for fat-soluble vitamin deficiency. Patients with active small bowel disease may require nutritional monitoring, with additional vitamin supplementation as necessary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Celiac disease – Patients with newly diagnosed celiac disease may have vitamin deficiencies. The evaluation at diagnosis should include laboratory screening for deficiencies and temporary supplementation as needed. After they have been effectively treated with a gluten-free diet, their vitamin requirements should be the same as for a healthy population. (See  <a class="medical medical_review" href="/z/d/html/4777.html" rel="external">"Management of celiac disease in adults", section on 'Repletion of nutritional deficiencies'</a> and  <a class="medical medical_review" href="/z/d/html/5907.html" rel="external">"Management of celiac disease in children", section on 'Screening and prevention of micronutrient deficiencies'</a>.)</p><p></p><p class="headingAnchor" id="H3754753222"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110557.html" rel="external">"Society guideline links: Vitamin deficiencies"</a>.)</p><p class="headingAnchor" id="H28"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> is a subclass of a family of lipid-soluble compounds referred to as retinoic acids. Because vitamin A from animal sources or supplements (eg, retinol) is preformed, it is more likely to cause toxicity than the provitamin A from plant sources (eg, <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>). (See <a class="local">'Chemistry'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> crucial to cellular differentiation and integrity in the eye, and deficiency causes xerophthalmia (dryness, fragility and clouding of the cornea)  (<a class="graphic graphic_picture graphicRef72297" href="/z/d/graphic/72297.html" rel="external">picture 2</a>). Vitamin A also has an important role in phototransduction, and deficiency causes night blindness. (See <a class="local">'Actions'</a> above and <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> deficiency is also associated with poor bone growth, nonspecific dermatologic problems (eg, hyperkeratosis), and impaired immune function. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">Vitamin A</a> deficiency is common among populations in resource-limited countries  (<a class="graphic graphic_figure graphicRef101071 graphicRef101072" href="/z/d/graphic/101071.html" rel="external">figure 1A-B</a>). In resource-limited regions where vitamin A deficiency is endemic, routine vitamin A supplementation in children ages 6 to 59 months is associated with decreased risk of mortality. Additional doses are given to individuals with xerophthalmia and children at high risk of vitamin A deficiency, such as those with measles, diarrhea, respiratory disease, or severe malnutrition. (See <a class="local">'Replacement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> deficiency is usually made by clinical findings but can be supported by measurement of serum retinol levels or the ratio of retinol:retinol-binding proteins (RBP); a molar ratio &lt;0.8 suggests deficiency). (See <a class="local">'Deficiency'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In populations where dietary intake of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> is adequate, there is no evidence that supplementation of vitamin A is helpful for preventing cardiovascular disease, and supplementation may even have harmful effects on cardiovascular mortality, cancer, and bone health. Therefore, in resource-rich countries where dietary intake of vitamin A is generally adequate, we recommend <strong>not</strong> supplementing vitamin A for disease prevention (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Atherosclerosis'</a> above and  <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">"Vitamin intake and disease prevention", section on 'Vitamin A and the carotenoids'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> toxicity occurs in adults when a single dose of &gt;660,000 units (&gt;200 mg) of vitamin A is ingested. Chronic toxicity occurs with long-term ingestion of vitamin A doses in amounts higher than 10 times the Recommended Dietary Allowance (RDA). Preformed vitamin A can have teratogenic effects during the first trimester of pregnancy, at doses of only several times the RDA. Circulating vitamin A concentrations do not consistently reflect vitamin A stores, because most vitamin A is stored in the liver; measurement of serum retinyl esters may be helpful. (See <a class="local">'Excess'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Wolf G. A history of vitamin A and retinoids. FASEB J 1996; 10:1102.</a></li><li><a class="nounderline abstract_t">Karrer P, Morf R, Schopp K. Zur Kenntnis des Vitamins‐A aus Fischtranen. Helv Chim Acta 1931; 14:1036.</a></li><li class="breakAll">Food and Nutrition Board of the Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2000). National Academies Press, Washington DC. Available at: https://www.nap.edu/read/10026/chapter/1 (Accessed on May 24, 2018).</li><li><a class="nounderline abstract_t">Harrison EH. Enzymes catalyzing the hydrolysis of retinyl esters. Biochim Biophys Acta 1993; 1170:99.</a></li><li><a class="nounderline abstract_t">Rigtrup KM, Ong DE. A retinyl ester hydrolase activity intrinsic to the brush border membrane of rat small intestine. Biochemistry 1992; 31:2920.</a></li><li><a class="nounderline abstract_t">Green MH, Green JB, Berg T, et al. Changes in hepatic parenchymal and nonparenchymal cell vitamin A content during vitamin A depletion in the rat. J Nutr 1988; 118:1331.</a></li><li><a class="nounderline abstract_t">Saari JC. Vitamin A metabolism in rod and cone visual cycles. Annu Rev Nutr 2012; 32:125.</a></li><li><a class="nounderline abstract_t">DOWLING JE. Chemistry of visual adaptation in the rat. Nature 1960; 188:114.</a></li><li><a class="nounderline abstract_t">See AW, Clagett-Dame M. The temporal requirement for vitamin A in the developing eye: mechanism of action in optic fissure closure and new roles for the vitamin in regulating cell proliferation and adhesion in the embryonic retina. Dev Biol 2009; 325:94.</a></li><li><a class="nounderline abstract_t">Morriss-Kay GM, Sokolova N. Embryonic development and pattern formation. FASEB J 1996; 10:961.</a></li><li><a class="nounderline abstract_t">Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004; 8:48.</a></li><li><a class="nounderline abstract_t">Zalesin KC, Miller WM, Franklin B, et al. Vitamin a deficiency after gastric bypass surgery: an underreported postoperative complication. J Obes 2011; 2011.</a></li><li class="breakAll">UNICEF. Coverage at a Crossroads: New directions for vitamin A supplementation programmes. New York: UNICEF; 2018. Available at: UNICEF. Coverage at a Crossroads: New directions for vitamin A supplementation programmes. New York: UNICEF; 2018 (Accessed on May 25, 2018).</li><li class="breakAll">World Health Organization (2009): Global prevalence of vitamin A deficiency in populations at risk, 1995–2005. Available at: http://apps.who.int/iris/bitstream/handle/10665/44110/9789241598019_eng.pdf;jsessionid=1B4D387FB0D678AA2BCAB045C230DE9B?sequence=1 (Accessed on May 24, 2018).</li><li class="breakAll">WHO, Vitamin and Mineral Nutrition Information System (VMNIS). Summary tables and maps on global prevalence of vitamin A deficiency 1995-2005. Available at: http://www.who.int/vmnis/database/vitamina/status/en/ (Accessed on May 25, 2018).</li><li><a class="nounderline abstract_t">Underwood BA, Arthur P. The contribution of vitamin A to public health. FASEB J 1996; 10:1040.</a></li><li><a class="nounderline abstract_t">Swami HM, Thakur JS, Bhatia SP. Impact of mass supplementation of vitamin A. Indian J Pediatr 2007; 74:443.</a></li><li><a class="nounderline abstract_t">Katz J, West KP Jr, Khatry SK, et al. Impact of vitamin A supplementation on prevalence and incidence of xerophthalmia in Nepal. Invest Ophthalmol Vis Sci 1995; 36:2577.</a></li><li><a class="nounderline abstract_t">Schmitz J, West KP Jr, Khatry SK, et al. Vitamin A supplementation in preschool children and risk of hearing loss as adolescents and young adults in rural Nepal: randomised trial cohort follow-up study. BMJ 2012; 344:d7962.</a></li><li><a class="nounderline abstract_t">Awasthi S, Peto R, Read S, et al. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet 2013; 381:1469.</a></li><li><a class="nounderline abstract_t">Imdad A, Mayo-Wilson E, Herzer K, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev 2017; 3:CD008524.</a></li><li><a class="nounderline abstract_t">Lin P, Fintelmann RE, Khalifa YM, et al. Ocular surface disease secondary to vitamin A deficiency in the developed world: it still exists. Arch Ophthalmol 2011; 129:798.</a></li><li><a class="nounderline abstract_t">de Pee S, Dary O. Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein. J Nutr 2002; 132:2895S.</a></li><li><a class="nounderline abstract_t">Greaves RF, Woollard GA, Hoad KE, et al. Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood. Clin Biochem Rev 2014; 35:81.</a></li><li><a class="nounderline abstract_t">Stephensen CB, Gildengorin G. Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2000; 72:1170.</a></li><li class="breakAll">World Health Organization Guideline: Vitamin A supplementation for infants and children 6-59 months of age (2011). Available at: http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_6to59_months/en/ (Accessed on May 24, 2018).</li><li><a class="nounderline abstract_t">Cantorna MT, Nashold FE, Hayes CE. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur J Immunol 1995; 25:1673.</a></li><li><a class="nounderline abstract_t">Cantorna MT, Nashold FE, Chun TY, Hayes CE. Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol 1996; 156:2674.</a></li><li><a class="nounderline abstract_t">Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity 2011; 35:13.</a></li><li><a class="nounderline abstract_t">Spencer SP, Wilhelm C, Yang Q, et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 2014; 343:432.</a></li><li class="breakAll">World Health Organization guideline: Vitamin A supplementation in pregnant women (2011). Available at: http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_pregnant/en/ (Accessed on April 07, 2015).</li><li class="breakAll">World Health Organization guideline: Vitamin A supplementation for infants 1–5 months of age (2011) http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_infants_1-5/en/ (Accessed on April 06, 2015).</li><li class="breakAll">World Health Organization guideline: Vitamin A supplementation in postpartum women (2011). Available at: http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_postpartum/en/ (Accessed on April 06, 2015).</li><li class="breakAll">World Health Organization guideline: Neonatal vitamin A supplementation (2011). Available at: http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_neonatal/en/ (Accessed on April 06, 2015).</li><li><a class="nounderline abstract_t">Imdad A, Ahmed Z, Bhutta ZA. Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age. Cochrane Database Syst Rev 2016; 9:CD007480.</a></li><li><a class="nounderline abstract_t">Haider BA, Bhutta ZA. Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in developing countries. Cochrane Database Syst Rev 2011; :CD006980.</a></li><li><a class="nounderline abstract_t">Neonatal Vitamin A Supplementation Evidence group. Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials. Arch Dis Child 2019; 104:217.</a></li><li class="breakAll">World Health Organization. Vitamin A supplements: a guide to their use in the treatment and prevention of vitamin A deficiency and xerophthalmia, 2nd Edition (1997). Available at: http://www.who.int/nutrition/publications/micronutrients/vitamin_a_deficiency/9241545062/en/ (Accessed on April 07, 2015).</li><li class="breakAll">World Health Organization. Guide for clinical case management and infection prevention and control during a measles outbreak. 2020. Available at: https://apps.who.int/iris/handle/10665/331599 (Accessed on February 17, 2022).</li><li><a class="nounderline abstract_t">Biesalski HK. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology 1989; 57:117.</a></li><li><a class="nounderline abstract_t">Myhre AM, Carlsen MH, Bøhn SK, et al. Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations. Am J Clin Nutr 2003; 78:1152.</a></li><li><a class="nounderline abstract_t">Geubel AP, De Galocsy C, Alves N, et al. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology 1991; 100:1701.</a></li><li><a class="nounderline abstract_t">Guarascio P, Portmann B, Visco G, Williams R. Liver damage with reversible portal hypertension from vitamin A intoxication: demonstration of Ito cells. J Clin Pathol 1983; 36:769.</a></li><li><a class="nounderline abstract_t">Weber FL Jr, Mitchell GE Jr, Powell DE, et al. Reversible hepatotoxicity associated with hepatic vitamin A accumulation in a protein-deficient patient. Gastroenterology 1982; 82:118.</a></li><li><a class="nounderline abstract_t">Olson JA. Upper limits of vitamin A in infant formulas, with some comments on vitamin K. J Nutr 1989; 119:1820.</a></li><li><a class="nounderline abstract_t">Soprano DR, Soprano KJ. Retinoids as teratogens. Annu Rev Nutr 1995; 15:111.</a></li><li><a class="nounderline abstract_t">Mahoney CP, Margolis MT, Knauss TA, Labbe RF. Chronic vitamin A intoxication in infants fed chicken liver. Pediatrics 1980; 65:893.</a></li><li><a class="nounderline abstract_t">Hathcock JN, Hattan DG, Jenkins MY, et al. Evaluation of vitamin A toxicity. Am J Clin Nutr 1990; 52:183.</a></li><li><a class="nounderline abstract_t">Lam HS, Chow CM, Poon WT, et al. Risk of vitamin A toxicity from candy-like chewable vitamin supplements for children. Pediatrics 2006; 118:820.</a></li><li><a class="nounderline abstract_t">Cheruvattath R, Orrego M, Gautam M, et al. Vitamin A toxicity: when one a day doesn't keep the doctor away. Liver Transpl 2006; 12:1888.</a></li><li><a class="nounderline abstract_t">Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 2006; 83:191.</a></li><li><a class="nounderline abstract_t">Smith FR, Goodman DS. Vitamin A transport in human vitamin A toxicity. N Engl J Med 1976; 294:805.</a></li><li><a class="nounderline abstract_t">Krasinski SD, Russell RM, Otradovec CL, et al. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. Am J Clin Nutr 1989; 49:112.</a></li><li><a class="nounderline abstract_t">Graham-Maar RC, Schall JI, Stettler N, et al. Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. Am J Clin Nutr 2006; 84:174.</a></li><li><a class="nounderline abstract_t">Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA 2002; 287:47.</a></li><li><a class="nounderline abstract_t">Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 2003; 348:287.</a></li><li><a class="nounderline abstract_t">Crandall C. Vitamin A intake and osteoporosis: a clinical review. J Womens Health (Larchmt) 2004; 13:939.</a></li><li><a class="nounderline abstract_t">Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995; 333:1369.</a></li><li><a class="nounderline abstract_t">Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database Syst Rev 2005; :CD001479.</a></li><li><a class="nounderline abstract_t">Bello S, Meremikwu MM, Ejemot-Nwadiaro RI, Oduwole O. Routine vitamin A supplementation for the prevention of blindness due to measles infection in children. Cochrane Database Syst Rev 2014; :CD007719.</a></li><li><a class="nounderline abstract_t">Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997; 53:358.</a></li><li><a class="nounderline abstract_t">Chomienne C, Fenaux P, Degos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 1996; 10:1025.</a></li><li><a class="nounderline abstract_t">Darlow BA, Graham PJ, Rojas-Reyes MX. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev 2016; :CD000501.</a></li><li><a class="nounderline abstract_t">Araki S, Kato S, Namba F, Ota E. Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis. PLoS One 2018; 13:e0207730.</a></li><li><a class="nounderline abstract_t">Fang JL, Sorita A, Carey WA, et al. Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis. Pediatrics 2016; 137.</a></li><li><a class="nounderline abstract_t">Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 1999; 69:1071.</a></li><li><a class="nounderline abstract_t">Feranchak AP, Gralla J, King R, et al. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology 2005; 42:782.</a></li><li class="breakAll">American Academy of Pediatrics Committee on Nutrition. Liver disease. In: Pediatric Nutrition, 8th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2019. p.1199.</li><li class="breakAll">Feranchak AP, and Sokol RJ. Medical and nutritional management of cholestasis in infants and children. In: Liver Disease in Children, 3rd, Suchy FJ, Sokol RJ, and Balistreri WF (Eds), Cambridge University Press, New York 2007. p.208.</li></ol></div><div id="topicVersionRevision">Topic 2571 Version 55.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8801174" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A history of vitamin A and retinoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Zur Kenntnis des Vitamins‐A aus Fischtranen</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Zur Kenntnis des Vitamins‐A aus Fischtranen</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8399348" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Enzymes catalyzing the hydrolysis of retinyl esters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1550818" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A retinyl ester hydrolase activity intrinsic to the brush border membrane of rat small intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3193250" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Changes in hepatic parenchymal and nonparenchymal cell vitamin A content during vitamin A depletion in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22809103" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Vitamin A metabolism in rod and cone visual cycles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13724150" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Chemistry of visual adaptation in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18955041" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The temporal requirement for vitamin A in the developing eye: mechanism of action in optic fissure closure and new roles for the vitamin in regulating cell proliferation and adhesion in the embryonic retina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8801178" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Embryonic development and pattern formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14746835" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20871833" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Vitamin a deficiency after gastric bypass surgery: an underreported postoperative complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20871833" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Vitamin a deficiency after gastric bypass surgery: an underreported postoperative complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20871833" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Vitamin a deficiency after gastric bypass surgery: an underreported postoperative complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20871833" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Vitamin a deficiency after gastric bypass surgery: an underreported postoperative complication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8801165" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The contribution of vitamin A to public health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17526954" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Impact of mass supplementation of vitamin A</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7499080" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Impact of vitamin A supplementation on prevalence and incidence of xerophthalmia in Nepal</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22234907" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Vitamin A supplementation in preschool children and risk of hearing loss as adolescents and young adults in rural Nepal: randomised trial cohort follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23498849" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28282701" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21670349" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Ocular surface disease secondary to vitamin A deficiency in the developed world: it still exists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12221267" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Biochemical indicators of vitamin A deficiency: serum retinol and serum retinol binding protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25210208" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11063445" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11063445" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7614995" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Vitamin A deficiency results in a priming environment conducive for Th1 cell development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8609382" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21777796" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The role of retinoic acid in tolerance and immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24458645" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24458645" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24458645" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24458645" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24458645" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27681486" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21975758" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30425075" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30425075" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30425075" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2665185" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Comparative assessment of the toxicology of vitamin A and retinoids in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14668278" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2019375" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6863568" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Liver damage with reversible portal hypertension from vitamin A intoxication: demonstration of Ito cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7198069" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Reversible hepatotoxicity associated with hepatic vitamin A accumulation in a protein-deficient patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2614529" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Upper limits of vitamin A in infant formulas, with some comments on vitamin K.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8527214" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Retinoids as teratogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7189278" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Chronic vitamin A intoxication in infants fed chicken liver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2197848" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Evaluation of vitamin A toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16882846" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Risk of vitamin A toxicity from candy-like chewable vitamin supplements for children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17133567" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Vitamin A toxicity: when one a day doesn't keep the doctor away.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16469975" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The acute and chronic toxic effects of vitamin A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/943041" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Vitamin A transport in human vitamin A toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2911996" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16825693" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11754708" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Vitamin A intake and hip fractures among postmenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12540641" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Serum retinol levels and the risk of fracture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15671709" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Vitamin A intake and osteoporosis: a clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7477116" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Teratogenicity of high vitamin A intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16235283" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Vitamin A for treating measles in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24436005" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Routine vitamin A supplementation for the prevention of blindness due to measles infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9074840" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Current use and future potential role of retinoids in dermatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8801163" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Retinoid differentiation therapy in promyelocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27552058" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30496228" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26962240" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10357725" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16175620" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Comparison of indices of vitamin A status in children with chronic liver disease.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
